ES2128592T3 - Procedimiento para preparar terc-leucina y analogos de la misma en forma enantiomerica y productos intermedios. - Google Patents

Procedimiento para preparar terc-leucina y analogos de la misma en forma enantiomerica y productos intermedios.

Info

Publication number
ES2128592T3
ES2128592T3 ES94931136T ES94931136T ES2128592T3 ES 2128592 T3 ES2128592 T3 ES 2128592T3 ES 94931136 T ES94931136 T ES 94931136T ES 94931136 T ES94931136 T ES 94931136T ES 2128592 T3 ES2128592 T3 ES 2128592T3
Authority
ES
Spain
Prior art keywords
enantiomerical
leucine
analogs
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94931136T
Other languages
English (en)
Inventor
Nicholas Turner
James Winterman
Raymond Mccague
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chirotech Technology Ltd
Original Assignee
Chirotech Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chirotech Technology Ltd filed Critical Chirotech Technology Ltd
Application granted granted Critical
Publication of ES2128592T3 publication Critical patent/ES2128592T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/83Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/42One oxygen atom attached in position 5
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

UNA NUEVA AZLACTONA DE LA FORMULA (III) O EL ENANTIOMERO OPUESTO, EN DONDE R1, R2, R3 Y X SON CADA UNO SUSTITUYENTES, SUFRE UNA BIOTRANSFORMACION, UTILIZANDO UNA ACTIVIDAD ENZIMATICA ADECUADA, EN LA PRESENCIA DE UNA BASE YH PARA FORMAR UN N-ACILOAMINOACIDO DE LA FORMULA (II) EN DONDE Y ES UN GRUPO DERIVABLE DE LA BASE YH Y CONVERTIBLE EN OH. UN AMINOACIDO DE LA FORMULA (I) O EL ENANTIOMERO, PUEDEN PREPARARSE CON UN ALTO E.E. A PARTIR DE UN COMPUESTO DE LA FORMULA (II) CONVIRTIENDO Y EN OH.
ES94931136T 1993-11-01 1994-11-01 Procedimiento para preparar terc-leucina y analogos de la misma en forma enantiomerica y productos intermedios. Expired - Lifetime ES2128592T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939322472A GB9322472D0 (en) 1993-11-01 1993-11-01 Chiral compounds and their preparation

Publications (1)

Publication Number Publication Date
ES2128592T3 true ES2128592T3 (es) 1999-05-16

Family

ID=10744442

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94931136T Expired - Lifetime ES2128592T3 (es) 1993-11-01 1994-11-01 Procedimiento para preparar terc-leucina y analogos de la misma en forma enantiomerica y productos intermedios.

Country Status (10)

Country Link
US (1) US6180374B1 (es)
EP (1) EP0726891B1 (es)
JP (1) JPH09504304A (es)
AT (1) ATE176461T1 (es)
AU (1) AU676786B2 (es)
CA (1) CA2173205A1 (es)
DE (1) DE69416424T2 (es)
ES (1) ES2128592T3 (es)
GB (1) GB9322472D0 (es)
WO (1) WO1995012573A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19529211C2 (de) * 1995-08-09 1999-01-14 Degussa Verfahren zur Herstellung von (R)-tertiär-Leucin
CN1215390A (zh) * 1996-04-02 1999-04-28 拜尔公司 取代的苯基酮烯醇杀虫剂及除草剂
GB9607458D0 (en) * 1996-04-10 1996-06-12 Zeneca Ltd Enzymatic process for stereoselective preparation of therapeutic amides
US6130337A (en) * 1997-04-11 2000-10-10 Board Of Trustees Of Leland Stanford Junior University Enantiomerically enriched α,α-distributed amino acids and method
JP2000319241A (ja) * 1999-04-28 2000-11-21 Ihara Chem Ind Co Ltd フェニルアルカン酸アミド化合物の製造方法
JP5647790B2 (ja) 2007-11-16 2015-01-07 株式会社カネカ N−カルバモイル−tert−ロイシンの製造法
CA2710683A1 (en) 2008-01-03 2009-07-16 Verenium Corporation Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
WO2010122682A1 (ja) 2009-04-24 2010-10-28 株式会社カネカ N-アルコキシカルボニル-tert-ロイシンの製造法
US8835676B2 (en) 2011-03-21 2014-09-16 Divi's Laboratories Ltd. Process for the preparation of enantiomerically pure tert-leucine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541080A (en) 1991-11-01 1996-07-30 Wisconsin Alumni Research Fdn. Method for preparing L-alpha-amino acids
US5219731A (en) * 1991-11-01 1993-06-15 Wisconsin Alumni Research Foundation Method for preparing optically-active amino acid derivatives

Also Published As

Publication number Publication date
EP0726891B1 (en) 1999-02-03
CA2173205A1 (en) 1995-05-11
WO1995012573A1 (en) 1995-05-11
JPH09504304A (ja) 1997-04-28
US6180374B1 (en) 2001-01-30
DE69416424D1 (de) 1999-03-18
AU676786B2 (en) 1997-03-20
EP0726891A1 (en) 1996-08-21
AU8001294A (en) 1995-05-23
ATE176461T1 (de) 1999-02-15
DE69416424T2 (de) 1999-06-10
GB9322472D0 (en) 1993-12-22

Similar Documents

Publication Publication Date Title
NO20083728L (no) Analogifremgangsmate for fremstilling av et terapeutisk aktivt nukleosid
CA2083041A1 (en) Labeled compounds for use in a diagnostic breath test
NZ330023A (en) Fused pyrrolecarboxanilides and their use as a GABA brain receptor ligands
DK0682561T3 (da) Omdannelse af kulstof eller kulstofholdige forbindelser i et plasma
ES2128592T3 (es) Procedimiento para preparar terc-leucina y analogos de la misma en forma enantiomerica y productos intermedios.
PH21581A (en) B-lactams and process for preparing the same
GB9314400D0 (en) Produktionsaktieselskab) chemical compounds
ES291543U (es) Una abrazadera enteriza en u mejorada de seccion transversal uniforme para fijacion como cierre.
ES2195312T3 (es) Copolimeros de alfa-olefina-cicloolefina y procedimiento para su preparacion.
DK0383686T3 (da) Carboxyalkylethere af 2-amino-7-hydroxytetralin samt fremgangsmåde til fremstilling deraf
EP0220951A3 (en) Biochemicals labelled with stable isotopes
EP0298336B1 (en) Aromatic polyisocyanates, process for their preparation and their use as components of adhesives
IN169689B (es)
ES8400109A1 (es) "un procedimiento para preparar esteres de acido 3-metilflavon-8-carboxilico".
TW333528B (en) Adhesion receptor antagonists
JPS571441A (en) Deodorizing agent
GR3002283T3 (en) Synthesis of peptidamides by the solid phase method using anchor groups unstable as to acids
HUT58766A (en) Process for producing new pentapeptides
DK0661263T3 (da) Fremgangsmåde til fremstilling af 2,4,5-tribrompyrrol-3-carbonitril
ES8308832A1 (es) Procedimiento para preparar derivados fluorados de diaminohepteno o -heptina.
MY129238A (en) Anticonvulsant derivatives useful in treating essential tremor
EP0074497A3 (en) Process for the preparation of 3-alkyl-6-methyl-beta-resorcylic-acid esters
JPS55114293A (en) Production of l-glutamic acid
ATE52258T1 (de) Verfahren zur herstellung von 2-beta-dribofuranosylselenazol-4-carboxamid.
EP0462556A3 (en) Hypotriglyceridemic use of certain bis(3,5-di-alkyl-4-hydroxphenylthio)methanes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 726891

Country of ref document: ES